| What about COVID-19 and arachidonic acid pathway? M Hoxha European Journal of Clinical Pharmacology, 2020 | 81 | 2020 |
| A systematic review on the role of eicosanoid pathways in rheumatoid arthritis M Hoxha Advances in medical sciences 63 (1), 22-29, 2018 | 80 | 2018 |
| The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field M Hoxha, GE Rovati, AB Cavanillas European Journal of Clinical Pharmacology 73, 799-809, 2017 | 55 | 2017 |
| Designing multitarget anti‐inflammatory agents: chemical modulation of the lumiracoxib structure toward dual thromboxane antagonists–COX‐2 inhibitors M Bertinaria, MAAG Shaikh, C Buccellati, C Cena, B Rolando, ... ChemMedChem 7 (9), 1647-1660, 2012 | 33 | 2012 |
| Folic acid and autism: a systematic review of the current state of knowledge B Hoxha, M Hoxha, E Domi, J Gervasoni, S Persichilli, V Malaj, ... Cells 10 (8), 1976, 2021 | 32 | 2021 |
| CYP-derived eicosanoids: Implications for rheumatoid arthritis M Hoxha, B Zappacosta Prostaglandins & Other Lipid Mediators 146, 106405, 2020 | 30 | 2020 |
| Duchenne muscular dystrophy: Focus on arachidonic acid metabolites M Hoxha Biomedicine & pharmacotherapy 110, 796-802, 2019 | 25 | 2019 |
| A potential role of PUFAs and COXIBs in cancer chemoprevention M Vara-Messler, C Buccellati, L Pustina, G Folco, GE Rovati, M Hoxha Prostaglandins & other lipid mediators 120, 97-102, 2015 | 24 | 2015 |
| The Importance of Nutraceuticals in COVID-19: What’s the Role of Resveratrol? E Domi, M Hoxha, E Kolovani, D Tricarico, B Zappacosta Molecules 27 (8), 2376, 2022 | 23 | 2022 |
| ATP-Sensitive potassium channel subunits in neuroinflammation: novel drug targets in neurodegenerative disorders F Maqoud, R Scala, M Hoxha, B Zappacosta, D Tricarico CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2022 | 21 | 2022 |
| Montelukast Use Decreases Cardiovascular Events in Asthmatics GE Hoxha, M., Tedesco, C. C., Quaglin, S., Malaj, V., Pustina, L., Capra, V ... Frontiers in Pharmacology 11 (611561), doi: 10.3389/fphar.2020.611561, 2021 | 17* | 2021 |
| Potential role of leukotriene receptor antagonists in reducing cardiovascular and cerbrovascular risk: A systematic review of human clinical trials and in vivo animal studies M Hoxha, AM Lewis-Mikhael, A Bueno-Cavanillas Biomedicine & Pharmacotherapy 106, 956-965, 2018 | 17 | 2018 |
| In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition M Hoxha, C Buccellati, V Capra, D Garella, C Cena, B Rolando, ... Pharmacological Research 103, 132-143, 2016 | 14 | 2016 |
| Dentists knowledge about over the counter-NSAIDs: an emerging need for NSAID-Avoidance Education M Hoxha, V Malaj, E Spahiu, M Spahiu Journal of Applied Pharmaceutical Science 10 (1), 070-076, 2020 | 9 | 2020 |
| A Systematic Review on the Role of Arachidonic Acid Pathway in Multiple Sclerosis Malvina Hoxha et al. CNS & Neurological Disorders - Drug Targets, 2020 | 8* | 2020 |
| A review on the role of fatty acids in colorectal cancer progression M Hoxha, B Zappacosta Frontiers in Pharmacology 13, 1032806, 2022 | 7 | 2022 |
| Arachidonic acid mediators and their role in neurological disease M Hoxha CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2022 | 6 | 2022 |
| THE INTERACTION BETWEEN ARACHIDONIC ACID METABOLISM AND HOMOCYSTEINE E Domi, M Hoxha 19th European Congress of internal medicine 8 (1), DOI: 10.12890/2021_V8Sup1, 2021 | 6 | 2021 |
| Compatibility of prolonged infusion antibiotics during Y‐site administration M Nunez‐Nunez, M Murillo‐Izquierdo, M Moya‐Martin, M Hoxha, ... Nursing in Critical Care 27 (6), 849-858, 2022 | 5 | 2022 |
| The role of montelukast in cardiovascular events M Hoxha, V Capra, V Malaj, A Sala, G Rovati Atherosclerosis 263, e150, 2017 | 5 | 2017 |
